Aducanumab Filed In Japan Despite Recent US Setback
Large Market Awaits If Approved
Biogen pushes ahead with approval submission in potentially large Japanese market, despite the negative views of a recent advisory committee in the US.
Biogen pushes ahead with approval submission in potentially large Japanese market, despite the negative views of a recent advisory committee in the US.